Latest Dividend Reinvestment Plans News

Westpac Banking Corporation has announced a fully franked interim dividend of AUD 0.76 per share for the half-year ending March 2025, payable in June with a Dividend Reinvestment Plan available to eligible shareholders.

VanEck Investments Limited has released a replacement Product Disclosure Statement for six Australian bond ETFs, reflecting updated reference indices and market conditions effective May 1, 2025.

Duxton Water Limited reported its strongest quarterly performance since inception, with NAV per share rising 17 cents to $1.71, driven by a $121.3 million sale of water entitlements to the Australian Government and strategic portfolio moves.

MFF Capital Investments Limited has updated its dividend details for the half-year ending December 2024, announcing a fully franked dividend of 8 cents per share and setting reinvestment prices for its DRP and BSP plans.

Nickel Industries delivered a robust US$97.3 million Adjusted EBITDA in Q1 2025 despite production challenges and a declining nickel price. Key milestones include approval to nearly double Hengjaya Mine’s ore sales quota and a strategic deferral of substantial ENC acquisition payments.

Cleanaway Waste Management Limited has announced a fully franked ordinary dividend of AUD 0.028 per share, payable on April 10, 2025, with a Dividend Reinvestment Plan available for shareholders.

Cleanaway Waste Management reported a 3.7% revenue increase to $1.94 billion for the half-year ending December 2024, while profit after tax remained flat at $74.2 million amid operational challenges including a significant fire at its St Marys facility.

EBOS Group Limited has announced a fully franked interim dividend of NZD 0.595 per share for the half-year ending December 2024, alongside a Dividend Reinvestment Plan offering a 2.5% discount.

Iluka Resources Limited has announced a fully franked ordinary dividend of AUD 0.04 per share for the financial year ending December 31, 2024, with key dates set for March 2025.

EBOS Group Limited posted robust interim results for H1 FY25, with underlying EBITDA rising 7.1% excluding the Chemist Warehouse Australia contract, driven by strong organic growth and strategic investments. The company maintained its dividend and reiterated FY25 EBITDA guidance between $575 million and $600 million.

EBOS Group Limited posted a strong half-year performance with underlying EBITDA up 7.1% to $291 million, driven by growth in healthcare and animal care segments, while maintaining its interim dividend amid the loss of the Chemist Warehouse contract.

EBOS Group Limited has reported a 9% drop in revenue and an 18.9% fall in net profit for the first half of fiscal 2025, yet it maintains its interim dividend at 57 NZ cents per share.